衰老诱导的IL27Ra信号损害造血干细胞
本研究揭示衰老相关炎症通过肿瘤坏死因子-α(TNF-α)→ERK→ETS1→白细胞介素27Ra(IL27Ra)通路促进造血干细胞(HSC)衰老。TNF-α随衰老升高并经ERK-ETS1信号诱导HSC表达IL27Ra;敲除IL27Ra可挽救HSC功能下降与髓系偏移,并逆转TNF-α对HSC的抑制作用。IL27Ra+ HSC重建能力受损且呈髓系偏移,炎症相关基因在其内富集并随衰老增强。
要点
- 衰老相关炎症经TNF-α→ERK→ETS1→IL27Ra通路促进HSC衰老
- 敲除IL27Ra可挽救HSC功能下降与髓系偏移,并逆转TNF-α的抑制作用
- IL27Ra+ HSC重建能力受损、呈髓系偏移,炎症相关基因富集随衰老增强
核心结论
- 衰老诱导的IL27Ra信号损害HSC,提示干扰IL27Ra信号可能对抗衰老对造血能力的生理性有害影响。
研究设计与样本
- 基础研究:在衰老小鼠中分析TNF-α→ERK→ETS1→IL27Ra通路对HSC衰老的作用,并比较IL27Ra敲除与野生型小鼠。
主要发现
- TNF-α随衰老升高,并经ERK-ETS1信号诱导HSC表达IL27Ra。
- 敲除IL27Ra可挽救HSC功能下降与髓系偏移,并逆转TNF-α对HSC的抑制作用。
- 衰老IL27Ra-/-小鼠髓系偏移HSC比例降低,未出现衰老野生型小鼠的髓系分化偏移。
- 与IL27Ra- HSC相比,IL27Ra+ HSC重建能力受损且呈髓系偏移,并在炎症刺激时作为髓系恢复池。
- 炎症相关基因在IL27Ra+ HSC中富集,且该富集随衰老增强。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hematopoietic stem cell (HSC) aging correlates with an increasing risk of myeloproliferative disease and immunosenescence. In this study, we show that aging-related inflammation promotes HSC aging through tumor necrosis factor-α (TNF-α)→ERK→ETS1→interleukin27Ra (IL27Ra) pathway. TNF-α, a well-known biomarker of inflammation, increases during aging and induces the expression of IL27Ra on HSCs via ERK-ETS1 signaling. Deletion of IL27Ra rescues the functional decline and myeloid bias of HSCs and also reverses the inhibitory effect of TNF-α on HSCs. Aged IL27Ra-/- mice had a reduced proportion of myeloid-biased HSCs and did not display the biased myeloid differentiation that occurs in aged wild-type mice. IL27Ra+ HSCs exhibit impaired reconstitution capacity and myeloid-bias compared with IL27Ra- HSCs and serve as a myeloid-recovery pool upon inflammatory insult. Inflammation-related genes were enriched in IL27Ra+ HSCs and this enrichment increases with aging. Our study demonstrates that age-induced IL27Ra signaling impairs HSCs and raises the possibility that interfering with IL27Ra signaling can counter the physiologically deleterious effect of aging on hematopoietic capacity.
引用
- He H, Xu P, Zhang X, et al. Aging-induced IL27Ra signaling impairs hematopoietic stem cells. Blood. 2020. PMID: 32305041. doi:10.1182/blood.2019003910
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。